These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 13671389)

  • 1. The formation of 6-mer captopurine riboside phosphate in ascites tumor cells.
    PATERSON AR
    Can J Biochem Physiol; 1959 Aug; 37(8):1011-23. PubMed ID: 13671389
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of ascites tumor growth by 4-aminopyrazolo-(3,4-d)pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine.
    HENDERSON JF; JUNGA IG
    Cancer Res; 1960 Dec; 20():1618-24. PubMed ID: 13713260
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic effects of 6-thioguanine. I. Studies on thioguanine-resistant and-sensitive Ehrlich ascites cells.
    SARTORELLI AC; LEPAGE GA; MOORE EC
    Cancer Res; 1958 Nov; 18(10):1232-9. PubMed ID: 13596970
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism of 6-thioguanine in normal and neoplastic tissues.
    MOORE EC; LePAGE GA
    Cancer Res; 1958 Oct; 18(9):1075-83. PubMed ID: 13596951
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of ascites cell growth by combinations of 6-thioguanine and azaserine.
    SARTORELLI AC; LEPAGE GA
    Cancer Res; 1958 Sep; 18(8 Part 1):938-42. PubMed ID: 13573368
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiopurine nucleotide synthesis in a 6-MP-resistant subline of the Ehrlich ascites carcinoma and growth inhibition by certain antimetabolites.
    PATERSON AR
    Can J Biochem Physiol; 1960 Oct; 38():1129-35. PubMed ID: 13733290
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-activity relationships among purines related to 6-mercaptopurine.
    CLARKE DA; ELION GB; HITCHINGS GH; STOCK CC
    Cancer Res; 1958 May; 18(4):445-56. PubMed ID: 13536996
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel derivatives of 6-mercaptopurine: synthesis, characterization and antiproliferative activities of S-allylthio-mercaptopurines.
    Miron T; Arditti F; Konstantinovski L; Rabinkov A; Mirelman D; Berrebi A; Wilchek M
    Eur J Med Chem; 2009 Feb; 44(2):541-50. PubMed ID: 18467007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
    Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
    Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary screening of cytotoxic activity of 6-purinyl-N-(2-chlordethyl) thiocarbamate.
    Miko M; Krepelka J; Melka M
    J Chemother; 1989 Jul; 1(4 Suppl):1142-4. PubMed ID: 16312809
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
    Saczewski F; Maruszak M; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of resistance to 6-mercaptopurine in a subline of the Ehrlich ascites carcinoma.
    PATERSON AR
    Can J Biochem Physiol; 1960 Oct; 38():1117-27. PubMed ID: 13733289
    [No Abstract]   [Full Text] [Related]  

  • 13. Adsorption of 6-mercaptopurine and 6-mercaptopurine-ribosideon silver colloid: a pH-dependent surface-enhanced Raman spectroscopy and density functional theory study. II. 6-mercaptopurine-riboside.
    Szeghalmi AV; Leopold L; Pînzaru S; Chis V; Silaghi-Dumitrescu I; Schmitt M; Popp J; Kiefer W
    Biopolymers; 2005 Aug; 78(6):298-310. PubMed ID: 15832317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold nanoparticles enhance the anti-leukemia action of a 6-mercaptopurine chemotherapeutic agent.
    Podsiadlo P; Sinani VA; Bahng JH; Kam NW; Lee J; Kotov NA
    Langmuir; 2008 Jan; 24(2):568-74. PubMed ID: 18052300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites.
    Nascimento I; Schaer R; Lemaire D; Freire S; Paule B; Carvalho S; Meyer R; Schaer-Barbosa H
    APMIS; 2004 Sep; 112(9):585-7. PubMed ID: 15601306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
    Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
    Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexose transport in ascites tumor cells.
    HOGG JF
    Med Bull (Ann Arbor); 1959 May; 25(5):177-84. PubMed ID: 13669190
    [No Abstract]   [Full Text] [Related]  

  • 18. [STUDIES ON ANTITUMOR DRUGS. III. THE USE OF IN VITRO CULTURE OF YOSHIDA ASCITES SARCOMA CELLS IN SCREENING ANTITUMOR SUBSTANCES].
    CHU TH; WU YI
    Yao Xue Xue Bao; 1963 Jun; 10():334-44. PubMed ID: 14070616
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
    Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM;
    Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INHIBITION OF INOSINE 5'-PHOSPHATE DEHYDROGENASE FROM EHRLICH ASCITES-TUMOUR CELLS BY 6-THIONINOSINE 5'-PHOSPHATE.
    ATKINSON MR; MORTON RK; MURRAY AW
    Biochem J; 1963 Oct; 89(1):167-72. PubMed ID: 14097359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.